Page 4 of Sun Pharma

Dilip Sanghvi, Dilip Sanghvi net worth, Dilip Sanghvi lifestyle, Dilip Sanghvi forbes, who is Dilip Sanghvi, Sun Pharma, Dilip Sanghvi Sun Pharma, lifestyle

Who is Indian billionaire Dilip Sanghvi, the man behind Sun Pharma? Know about his Rs 15.65 lakh crore net worth

Founder of Sun Pharma, Shanghvi commands a business empire generating $5.4 billion (approximately Rs 44,971 crore) in revenue.

Updated: December 21, 2023 00:37 IST

Sun Pharma, Taro, acquisition, shares, investment, merger, generic dermatology market

Sun Pharma inks licensing pact with Aclaris Therapeutics for autoimmune disorder drug

The agreement has been signed between Sun Pharmaceutical Industries, Inc. Aclaris Therapeutics.

December 6, 2023 13:35 IST

Sun Pharma’s shares advance on Q2 results; Should you buy, hold or sell the stock?

Sun Pharma’s share price gained 1.48% in the last five days, while it dropped 1.13% in the last one month.…

Updated: November 2, 2023 11:28 IST

Sun Pharma, Bayer, Bayer pharma, cardiac care, heart patients, healthcare news, pharma news,

Sun Pharma Q2 Results: Profit rises 5% to Rs 2375.51 crore, beats estimates

Sun Pharma posted revenue from operations at Rs 12,192.41 crore, up 11.3 per cent as against Rs 10,952.28 crore during…

November 1, 2023 15:49 IST

Divi's Laboratories, Pharmaceutical, pharma industry, Q2FY24 results, profit, revenue, EBITDA

Sun Pharma and Zydus sign licensing agreement to co-market critical drug for Chronic Kidney Disease patients in India

Under the terms of this agreement, Zydus has granted Sun Pharma semi-exclusive rights to co-market the product in India.

October 30, 2023 13:23 IST

Sun Pharma, Philogen, Melanoma, Skin cancer, healthcare news, pharma news,

Sun Pharma and Philogen’s melanoma drug shows promising outcome in Phase 3 trial

On May 30, 2023, Philogen and Sun Pharma entered into a distribution, license, and supply agreement for commercializing Nidlegy in…

October 16, 2023 17:20 IST

Sun Pharma, Eye diseases, Eye disorder, dry eyes, trial results, healthcare news, pharma news,

Sun Pharma’s eye drug shows promising results in Phase 4 trial

CEQUA was generally well tolerated in the study, consistent with its established safety profile, and there were no new safety…

October 13, 2023 12:25 IST

Sun Pharma launches novel topical treatment for acne in Canada

WINLEVI is the first and only topical androgen receptor inhibitor, and the newest Health Canada-approved formulation to target the hormonal…

September 27, 2023 14:28 IST

Generic medicines, biosimilars, Cipla, Sun Pharma, healthcare news, pharma news,

Generic and biosimilar products are still out of reach for many patients in LMICs, reveals new report

Of the medicines classed as “essential” by the World Health Organization (WHO), 90 percent are off patent, including treatments for…

September 26, 2023 15:06 IST

Sun Pharma posts Q1 profit at Rs 2022.54 cr on low profitability at Taro; MD says well positioned to meet FY24 guidance

Sun Pharmaceutical posted revenue from operations at Rs 11,940.84 crore, up 11 per cent as against Rs 10,761.76 crore during…

August 4, 2023 11:41 IST

Sun Pharma and Philogen enter into exclusive agreement for commercialising skin cancer drug in Europe, Australia and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy for indications of skin cancers…

May 31, 2023 11:13 IST

Sun Pharma proposes to fully acquire Israel-based Taro Pharmaceutical Industries

Sun Pharmaceutical Industries on Saturday said it has proposed to fully acquire Israel-based Taro Pharmaceutical Industries through a reverse triangular…

May 27, 2023 17:50 IST

Sun Pharma, fourth quarter, Q4FY23 results, profit, revenue, dividend

Sun Pharma posts Q4FY23 profit at Rs 1,984.47 crore, revenue up 15.7% on-year; dividend declared

Sun Pharma posted revenue from operations at Rs 10,930.67 crore, up 15.7 per cent as against Rs 9,446.76 crore in…

May 26, 2023 15:27 IST

Dilip Shanghvi net worth, who is dilip shanghvi, dilip shanghvi journey,, Sun Pharmaceutical Industries Limited, entrepreneur, healthcare industry, affordable medicines, generic and branded pharmaceutical products, business family, net worth, low-key lifestyle, philanthropy, sun foundation.

Meet Padma Shri Dilip Shanghvi, a visionary who transformed Indian healthcare industry: Know about his journey, education, net worth and more

In this article, we will take a look at Shanghvi’s journey, family, education, net worth and more.

April 29, 2023 09:00 IST

Sun Pharma launches novel therapy for Dry Eye Disease in India

The prevalence of DED in India is higher than the global prevalence and a large regional study pegged India’s prevalence…

April 25, 2023 15:48 IST

Sun Pharma, Q3FY22, quarterly results, Sun pharma results, healthcare news, pharma news,

Sun Pharma reports rise in net profit by 5 percent to Rs. 2,166 crore yoy in Q3FY22

Earlier, Sun Pharma had paid interim dividend of ₹7 per share for the previous financial year 2021-22.

January 31, 2023 14:47 IST

Sun Pharma: Speciality pipeline gets a boost

The deal will help gain access to Concert’s drug to treat baldness

January 23, 2023 02:30 IST

stocks to watch, stocks in focus, reliance Q3 results, RIL, HUL

Reliance Industries, HUL, Sun Pharma, PVR, Asian Paints, TCS, Hindustan Zinc, LTTS, JSW Energy stocks in focus

SGX Nifty hints at a flat to positive start for Indian benchmark indices BSE Sensex and NSE Nifty 50. Mukesh…

January 20, 2023 07:13 IST

Related News

stranger things season 5 volume 2 release date

Stranger Things Season 5 Volume 2 release in India: Exact date and time to watch latest episodes

FIIs & DIIs bet big: A strategic pivot beyond the AC boom. (Image Source: Canva)

Not Voltas, not Dixon: The one AC stock FIIs & DIIs are aggressively buying

Meta CEO Mark Zuckerberg’s highest-paid employee Alexandr Wang tells teens how to build a lucrative tech future

PMI Electro Dominates India’s Largest E-Bus Tender

Centre wraps up mega e-bus tender; PMI bags half of 10,900 buses

8th Pay Commission Rules: No DA increase, pension revision for central government pensioners?

8th Pay Commission News: No DA increase, pension revision for central government pensioners? Fact checked

Who is Tea Tyme? TikToker arrested, accused of killing pedestrian while livestreaming

World News25 min ago

TikToker Tea Tyme, real name Tynesha McCarty-Wroten, was arrested on Christmas Eve for allegedly hitting and killing a pedestrian while livestreaming in November. The victim, 59-year-old Darren Lucas, was walking home from work. McCarty-Wroten was charged with reckless homicide and aggravated use of an electronic communication device.

View all shorts